Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
mBio
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Latest Articles
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • Topics
    • Applied and Environmental Science
    • Clinical Science and Epidemiology
    • Ecological and Evolutionary Science
    • Host-Microbe Biology
    • Molecular Biology and Physiology
    • Therapeutics and Prevention
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About mBio
    • Editor in Chief
    • Board of Editors
    • AAM Fellows
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
Research Article | Host-Microbe Biology

Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission

Tonia Zangari, Mila B. Ortigoza, Kristen L. Lokken-Toyli, Jeffrey N. Weiser
Justin A. Thornton, Editor
Tonia Zangari
aDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mila B. Ortigoza
aDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
bDepartment of Medicine, Division of Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristen L. Lokken-Toyli
aDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey N. Weiser
aDepartment of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeffrey N. Weiser
Justin A. Thornton
Mississippi State University
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/mBio.03589-20
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Supplemental Material
  • FIG 1
    • Open in new tab
    • Download powerpoint
    FIG 1

    Type I interferon is necessary for and promotes high-level shedding of S. pneumoniae and IAV. WT and Ifnar1−/− pups were infected i.n. with 103 CFU S. pneumoniae (Spn), 250 PFU IAV-x31, or S. pneumoniae plus IAVx31. (A and B) Ifnar1−/− pups shed significantly fewer bacteria than WT pups (A), and Ifnar1−/− pups shed significantly less IAV than WT pups (B). (C) WT and Ifnar1−/− pups first received IAV and then S. pneumoniae. Ifnar1−/− pups shed significantly fewer bacteria than WT pups. (D and E) Exogenous recombinant IFN-α2 or IFN-β increase pneumococcal shedding from WT but not Ifnar1−/− mice. WT and Ifnar1−/− pups were infected i.n. with 103 CFU S. pneumoniae and daily received either 1,000 IU of recombinant mouse IFN-α2 or 1,000 to 5,000 IU of recombinant mouse IFN-β or vehicle control (0.1% BSA-PBS) by i.n. instillation. Treatment of WT pups with rIFN-α2 (D) or rIFN-β (E) was sufficient to increase pneumococcal shedding over the baseline. Shedding data are shown as a Tukey box-and-whisker plot, with outliers shown as symbols. Each symbol represents the value from an individual pup on a single day. n ≥ 8 pups/group. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Mann-Whitney test).

  • FIG 2
    • Open in new tab
    • Download powerpoint
    FIG 2

    Pneumococci are shed and stimulate IFN-I at 21 days p.i. in a pneumolysin-dependent manner. (A and B) WT pups were infected i.n. with 103 CFU S. pneumoniae; mock-treated mice received PBS. RNA was isolated from URT lavages on day 21 p.i. and analyzed by RNA-seq. Shown is a heat map of 543 genes identified as the interferome, comparing S. pneumoniae to mock infection (A) or S. pneumoniae to the S. pneumoniae ply mutant strain (B), demonstrating relative gene expression as log2 fold change, with increased expression in red and decreased expression in blue. n = 5 mice per group. (C) RNA was isolated from URT lavages on day 21 p.i. and analyzed by qRT-PCR. At 21 days p.i., S. pneumoniae-infected mice showed significantly increased expression of the ISGs Ifit2, Mx1, and Oasl2 over mock-infected mice. This increased expression was seen only in WT and not Ifnar1−/− mice. (D to F) WT pups were infected i.n. with 103 CFU S. pneumoniae T4 or T23F (D), or WT and Ifnar1−/− pups were infected i.n. with 103 CFU S. pneumoniae T4 or an isogenic T4 ply mutant (E and F). (D) T4 and T23F are shed 21 days p.i., which correlates with gene expression data. (E) At 21 days p.i., there are more high-shedding events (>200) in S. pneumoniae-infected mice than mice infected with the isogenic S. pneumoniae ply mutant. (F) At 21 days p.i., there is no difference in the number of high-shedding events between S. pneumoniae and S. pneumoniae ply mutant strains in Ifnar1−/− mice. Gene expression data are log10 transformed; each symbol represents the value from an individual pup, and the line represents the mean. Comparisons (Mann-Whitney test) are to mock-infected mice of the respective genotypes. Shedding data are shown as Tukey box-and-whisker plots, with outliers shown as symbols. Each symbol represents the value from an individual pup on a single day. n ≥ 8 pups/group. ns, not significant; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 (Mann-Whitney test); #, P = 0.03 (one-tailed Fisher’s exact test).

  • FIG 3
    • Open in new tab
    • Download powerpoint
    FIG 3

    S. pneumoniae and IAV stimulate IFN-I signaling at 48 h p.i. WT and Ifnar1−/− pups were infected i.n. with 103 CFU the S. pneumoniae T4 or T4Δply mutant, 250 PFU IAV, or T4 plus IAV; mock-infected mice received PBS. RNA was isolated from URT lavages 48 h p.i. and analyzed by qRT-PCR. S. pneumoniae-infected mice showed significantly increased expression of the ISGs Ifit2, Mx1, and Oasl2 compared to that of mock-infected mice. This increased expression was seen only in WT and not Ifnar1−/− mice. The stimulation of ISGs by S. pneumoniae was ply dependent. Gene expression data are log10 transformed; each symbol represents the value from an individual pup. Comparisons (Mann-Whitney test) are to mock-infected mice of the respective genotype. n ≥ 5 pups/group. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

  • FIG 4
    • Open in new tab
    • Download powerpoint
    FIG 4

    S. pneumoniae colonization increases nasal secretions of pups. (A and B) WT and Ifnar1−/− pups were infected i.n. with 103 CFU S. pneumoniae or 250 PFU IAV; mock-infected mice received PBS. RNA was isolated from URT lavages 48 h (A) or 21 days (B) p.i. and analyzed by qRT-PCR. S. pneumoniae-infected mice showed significantly increased expression of the ISG sialyltransferase St3gal1 over mock-infected mice. This increased expression was seen only in WT and not Ifnar1−/− mice. The stimulation of ISGs by S. pneumoniae was also ply dependent. Gene expression data are log10 transformed; each symbol represents the value from an individual pup, and the line represents the mean. Comparisons (Mann-Whitney test) are to mock-infected mice of the respective genotype. n ≥ 5 pups/group. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001. (C) Pups infected with IAV or S. pneumoniae secreted more sialic acid from their nares than pups that received PBS. IAV comparisons are days 14 to 18 p.i. to matched PBS controls; S. pneumoniae comparisons are of days 9 to 12 p.i. The increase in nasal secretions from S. pneumoniae-infected pups is IFN-I dependent, as there was no difference detected in sialic acid shed from infected Ifnar1−/− pups compared to PBS controls (days 9 to 12 p.i.). WT and Ifnar1−/− pups were infected i.n. with either 103 CFU S. pneumoniae T23F P2636 (neuraminidase mutant) or 250 PFU IAV-x31 or received PBS. Band integrated pixel density data are for individual pups, with the bar indicating the median. Each symbol represents the value from an individual pup on a single day. n ≥ 3 pups/group. ns, not significant; *, P < 0.05; **, P < 0.01; ***, P < 0.001 (Mann-Whitney test).

  • FIG 5
    • Open in new tab
    • Download powerpoint
    FIG 5

    Lack of IFN-I signaling reduces transmission of IAV and S. pneumoniae. (A) WT and Ifnar1−/− index pups were infected i.n. with 103 CFU S. pneumoniae at a ratio of 6 index to 20 contact in WT litters or 5 index to 18 contact in Ifnar1−/− mice in three separate litters. The S. pneumoniae transmission rate and bacterial burden were higher in WT than Ifnar1−/− contact mice. (B) WT and Ifnar1−/− index pups were infected i.n. with 250 PFU IAV at a ratio of 12 index to 22 contact in WT litters or 10 index to 28 contact in Ifnar1−/− mice in five separate litters. The IAV titer was higher in WT than Ifnar1−/− contact mice. Colonization and titer data are for individual pups, with the line indicating the geometric mean. Each symbol represents the value from an individual pup on a single day. n ≥ 5 pups/group. *, P < 0.05; ***, P < 0.001 (Mann-Whitney test). The dotted line shows the limit of detection.

Supplemental Material

  • Figures
  • FIG S1

    S. pneumoniae colonization and IAV titer do not differ in WT and Ifnar1−/− pups. Pups were infected i.n. with either 103 CFU S. pneumoniae or 250 PFU IAV-x31. (A) S. pneumoniae URT colonization was not different between WT and Ifnar1−/− pups. (B) There was no difference in viral titer in the URT of WT and Ifnar1−/− pups. (C) WT and Ifnar1−/− pups first received IAV and then S. pneumoniae; bacterial colonization was not different between pups. (D and E) WT and Ifnar1−/− pups were infected i.n. with 103 CFU S. pneumoniae and daily received 1,000 IU of recombinant mouse IFN-α2 or 1,000 to 5,000 IU of recombinant mouse IFN-β or vehicle control (0.1% BSA-PBS) by i.n. instillation. Treatment of WT pups with rIFN-α2 (D) or rIFN-β (E) did not affect bacterial colonization. Colonization and titer data are for individual pups, with the line indicating the geometric mean. Each symbol represents the value from an individual pup on a single day. n ≥ 8 pups/group. ns, not significant (Mann-Whitney test). The dotted line shows the limit of detection. Download FIG S1, PDF file, 0.2 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S2

    S. pneumoniae T4 and T23F colonization at 21 days p.i. does not differ in WT and Ifnar1−/− mice. (A to C) WT pups were infected i.n. with 103 CFU S. pneumoniae T4 or T23F (A), or WT and Ifnar1−/− pups were infected i.n. with 103 CFU S. pneumoniae T4 or an isogenic T4 ply mutant; colonization was assessed 21 days p.i. (B and C). (A) The mice are still highly colonized with S. pneumoniae of both T4 and T23F serotypes. (B) Colonization of T4 and the isogenic T4 ply mutant strain is not different. (C) At 21 days p.i., there is no difference in the colonization between T4 and T4 ply mutant strains in Ifnar1−/− mice. Colonization data are for individual pups, with the line indicating the geometric mean. Each symbol represents the value from an individual pup on a single day. n ≥ 8 pups/group. ns, not significant by Mann-Whitney test. Download FIG S2, PDF file, 0.2 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • TABLE S1

    Genes upregulated in S. pneumoniae-infected mice over PBS mice at 21 days p.i. Mice received S. pneumoniae T23F or PBS, i.n., on day 4 of life; on day 21 p.i., the mice were euthanized and RNA was collected by URT lavage. Download Table S1, XLSX file, 0.1 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • TABLE S2

    Interferome analysis of genes upregulated in S. pneumoniae-infected mice at 21 days p.i. The 915 genes identified in the RNA-seq were determined to be ISGs (n = 543) by use of the Interferome database, v2.01, at http://www.interferome.org/interferome/home.jspx (18). Download Table S2, XLSX file, 0.03 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S3

    Immunoblot of S. pneumoniae strains for pneumolysin. S. pneumoniae serotypes T4 and T23F used in this study do not produce different levels of pneumolysin. Download FIG S3, PDF file, 0.4 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • FIG S4

    Increased expression of Ifna and Ifnb was not detected at 48 h p.i. in mice that had received S. pneumoniae. WT pups were infected i.n. with 103 CFU S. pneumoniae T4 or 250 PFU IAV; mock-infected mice received PBS. RNA was isolated from URT lavages 48 h p.i. and analyzed by qRT-PCR. S. pneumoniae-infected mice showed no increased expression of Ifna or Ifnb over mock-infected mice. This increased expression was seen only in IAV-infected mice. Gene expression data are log10 transformed; each symbol represents the value from an individual pup. Comparisons (Mann-Whitney test) are to mock-infected mice. n ≥ 5 pups/group. ns, not significant; **, P < 0.01. Download FIG S4, PDF file, 0.2 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

  • TABLE S3

    Primers (forward and reverse) used in RT-PCR analysis of the expression of interferon stimulated genes (plus Gapdh control) from the mouse upper respiratory tract. Download Table S3, DOCX file, 0.01 MB.

    Copyright © 2021 Zangari et al.

    This content is distributed under the terms of the Creative Commons Attribution 4.0 International license.

PreviousNext
Back to top
Download PDF
Citation Tools
Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission
Tonia Zangari, Mila B. Ortigoza, Kristen L. Lokken-Toyli, Jeffrey N. Weiser
mBio Feb 2021, 12 (1) e03589-20; DOI: 10.1128/mBio.03589-20

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this mBio article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission
(Your Name) has forwarded a page to you from mBio
(Your Name) thought you would be interested in this article in mBio.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission
Tonia Zangari, Mila B. Ortigoza, Kristen L. Lokken-Toyli, Jeffrey N. Weiser
mBio Feb 2021, 12 (1) e03589-20; DOI: 10.1128/mBio.03589-20
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

influenza virus
interferon
pneumococcus
transmission

Related Articles

Cited By...

About

  • About mBio
  • Editor in Chief
  • Board of Editors
  • AAM Fellows
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Author Warranty
  • Article Types
  • Ethics
  • Contact Us

Follow #mBio

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Online ISSN: 2150-7511